Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer.
Peters S, Shaw AT, Besse B, Felip E, Solomon BJ, Soo RA, Bearz A, Gadgeel SM, Lin CC, Kao S, Seto T, Masters ET, Abbattista A, Clancy JS, Thurm H, Reisman A, Peltz G, Ross Camidge D. Peters S, et al. Among authors: solomon bj. Lung Cancer. 2020 Jun;144:10-19. doi: 10.1016/j.lungcan.2020.02.011. Epub 2020 Mar 10. Lung Cancer. 2020. PMID: 32344248
An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic.
Degeling K, Baxter NN, Emery J, Jenkins MA, Franchini F, Gibbs P, Mann GB, McArthur G, Solomon BJ, IJzerman MJ. Degeling K, et al. Among authors: solomon bj. Asia Pac J Clin Oncol. 2021 Aug;17(4):359-367. doi: 10.1111/ajco.13505. Epub 2021 Feb 10. Asia Pac J Clin Oncol. 2021. PMID: 33567163 Free PMC article.
Current highlights in lung cancer in 2021.
Lim KHJ, Solomon BJ. Lim KHJ, et al. Among authors: solomon bj. ESMO Open. 2021 Oct;6(5):100245. doi: 10.1016/j.esmoop.2021.100245. Epub 2021 Aug 17. ESMO Open. 2021. PMID: 34416470 Free PMC article. No abstract available.
LOREALAUS: LOrlatinib REAL-World AUStralian Experience in Advanced ALK-Rearranged NSCLC.
Alexander M, Wei J, Parakh S, John T, Kao S, Nagrial A, Bowyer S, Warburton L, Moore M, Hughes BGM, Clay TD, Pavlakis N, Solomon BJ, Itchins M. Alexander M, et al. Among authors: solomon bj. JTO Clin Res Rep. 2023 Feb 26;4(4):100490. doi: 10.1016/j.jtocrr.2023.100490. eCollection 2023 Apr. JTO Clin Res Rep. 2023. PMID: 37077199 Free PMC article.
Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer.
Blackhall F, Ross Camidge D, Shaw AT, Soria JC, Solomon BJ, Mok T, Hirsh V, Jänne PA, Shi Y, Yang PC, Pas T, Hida T, Carpeño JC, Lanzalone S, Polli A, Iyer S, Reisman A, Wilner KD, Kim DW. Blackhall F, et al. Among authors: solomon bj. ESMO Open. 2017 Aug 17;2(3):e000219. doi: 10.1136/esmoopen-2017-000219. eCollection 2017. ESMO Open. 2017. PMID: 29209525 Free PMC article.
Targeting platelets for improved outcome in KRAS-driven lung adenocarcinoma.
Hyslop SR, Alexander M, Thai AA, Kersbergen A, Kueh AJ, Herold MJ, Corbin J, Gangatirkar P, Ng AP, Solomon BJ, Alexander WS, Sutherland KD, Josefsson EC. Hyslop SR, et al. Among authors: solomon bj. Oncogene. 2020 Jul;39(29):5177-5186. doi: 10.1038/s41388-020-1357-6. Epub 2020 Jun 13. Oncogene. 2020. PMID: 32535617
140 results